ENTITY
NovaBridge Biosciences

NovaBridge Biosciences (NBP US)

68
Analysis
Health Care • China
NovaBridge Biosciences is a biopharmaceutical company. The Company specializes in discovery, development, and commercialization of novel biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders. NovaBridge Biosciences operates globally.
more
•07 Aug 2026 08:04

Primer: NovaBridge Biosciences (NBP US) - Aug 2026

NovaBridge Biosciences is a clinical-stage biopharmaceutical company focused on the high-growth areas of oncology and autoimmune disorders. Its...

Logo
114 Views
Share
•14 Feb 2024 15:46

Musings On US-Listed China Plays

Investors in Chinese companies may be willing to support activities that are contrary to US national interests, including technology used for...

Logo
706 Views
Share
•21 Jul 2026 10:17•Broker

Pakistan Banks: Earnings to Decrease 10% QoQ in 2Q2026; Led by Absence of Abnormal Capital Gain

Topline Banking Universe is likely to post an earnings decline of 1% YoY in 2Q2026, due to a higher operating expenses coupled with provision...

Logo
114 Views
Share
•07 Jul 2026 16:55•Broker

Pakistan Banks: Central Bank Amends MDR Rules; MDR Removed on Trusts, Pvt Limited, and Individuals

The State Bank of Pakistan (SBP) has removed the Minimum Deposit Rate (MDR) requirement on Trusts, Private limited businesses and for Individual...

Logo
140 Views
Share
•22 Jun 2026 23:17

China Healthcare Weekly Wrap (15-21 June)

​Hengrui releases China phase 3 data for oral GLP-1 HRS7535 in T2D; Harbour/BioMap for AI- company MegaStream. Other updates: Legend, Everest,...

Logo
107 Views
Share
x